Baodong Sun

Harbin Normal University — China

Medicine · Health Sciences

35h-index3.1kcitations111works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glycogen Storage Diseases and Myoclonus(40), Lysosomal Storage Disorders Research(39), Genetics and Neurodevelopmental Disorders(19), Virus-based gene therapy research(11), Carbohydrate Chemistry and Synthesis(11)

Publications111 total

Novel promoters drive therapeutic transgene expression and evade transgene-specific immune responses in a mouse model of Pompe disease
Molecular Genetics and Metabolism·2025
Application and Breakthrough of CRISPR-Cas9 Gene Editing Technology in the Clinical Treatment of Sickle Cell Disease
MedScien·2025Open Access
Organ-Agents: Virtual Human Physiology Simulator via LLMs
arXiv (Cornell University)·2025Open Access
High-potency MyoAAV capsids enhanced skeletal muscle correction in a mouse model of GSD IIIa
Molecular Therapy — Methods & Clinical Development·2025· 1 citedOpen Access
A room-temperature RF magnetron sputtering synthesis of amorphous Bi2O3 films for self-powered UV photodetector
Materials Science in Semiconductor Processing·2025· 4 cited
Long‐Term Correction of Murine Glycogen Storage Disease Type III by AAV‐Mediated Gene Therapy Using an Immunotolerizing Dual Promoter to Express Bacterial Pullulanase
Advances in Cell and Gene Therapy·2025· 1 citedOpen Access
One-Dimensional Nickel Molybdate Nanostructures with Enhanced Supercapacitor Performance
Polymers·2023· 4 citedOpen Access
Scurvy in a young man: a rare case report
Frontiers in Nutrition·2023· 6 citedOpen Access
Gene therapy for glycogen storage diseases
Journal of Inherited Metabolic Disease·2023· 28 citedOpen Access
Successful AAV8 readministration: Suppression of capsid‐specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease
The Journal of Gene Medicine·2023· 13 citedOpen Access
P173: Establishing preclinical efficacy for the first AAV gene therapy for GSD IX γ2 across stages of progressive liver disease
Genetics in Medicine Open·2023Open Access
Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice
JCI Insight·2022· 14 citedOpen Access
Correction to: Evaluation of carbon neutrality capacity based on a novel comprehensive model
Environmental Science and Pollution Research·2022· 2 citedOpen Access
Evaluation of carbon neutrality capacity based on a novel comprehensive model
Environmental Science and Pollution Research·2022· 14 cited
SEVERE PROGRESSION OF LIVER DISEASE IN AN AGING PHKG2 MOUSE MODEL RECAPITULATES GSD IX G2 PATIENT PHENOTYPE
Molecular Genetics and Metabolism·2022
Preparation of carbon-based metal organic framework-modified molecularly imprinted polymers for selective recognition of bovine hemoglobin in biological samples
New Journal of Chemistry·2022· 5 cited
Metal oxide–based macroporous ordered double affinity molecularly imprinted polymer for specific separation and enrichment of glycoprotein from food samples: a co-modification of DMSA and boronate affinity
Microchimica Acta·2022· 18 cited
New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside
Journal of Clinical Medicine·2021· 17 citedOpen Access
Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2/ mouse model
Molecular Genetics and Metabolism·2021· 8 citedOpen Access
Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2−/− mouse model
Molecular Genetics and Metabolism·2021
page 1 of 6Next →

Frequent Co-authors

Dwight D. Koeberl(21), Andrew Bird(15), Priya S. Kishnani(15), Andrew V. Schally(14), Haiqing Yi(9), Songtao Li(8), Gábor Halmos(7), Sarah P. Young(7), Haoyue Zhang(6), T. T. Brown(6), Károly Szepesházi(6), Attila Nagy(5), Jeong‐A Lim(5), Beth L. Thurberg(5), Ayn Schneider(4), Andrea Amalfitano(4), Kate Groot(4), Hippokratis Kiaris(4), Patricia Armatis(4), Francine Hébert(4)